NCT03365596

Brief Summary

Prediction of recovery from stroke can assist in the planning of impairment-focused rehabilitation. To achieve better prediction for clinical purposes, this study investigated a new prediction model with low inter-individual variability and high accuracy using neuroimaging techniques.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 27, 2017

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 7, 2017

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2022

Completed
27 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 26, 2023

Completed
Last Updated

March 8, 2023

Status Verified

July 1, 2019

Enrollment Period

5.6 years

First QC Date

November 27, 2017

Last Update Submit

March 7, 2023

Conditions

Stroke

Keywords

Brain connectivityMagnetic resonance imagingRecovery prediction

Outcome Measures

Primary Outcomes (1)

  • Fugl-Meyer Assessment score at 3 months after stroke onset

    Measurement of motor function of upper and lower extremities

    3 months after stroke onset

Study Arms (1)

Subacute stroke

Other: Conventional therapy

Interventions

Conventional therapyOTHER

According to the status of a patient, optimized therapy will be applied.

Subacute stroke

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

First-ever stroke patients at subacute stage.

You may qualify if:

  • First-ever stroke patients
  • Unilateral stroke
  • Subacute stage (less than 4 weeks)

You may not qualify if:

  • Major active neurological disease or psychiatric disease
  • A history of seizure
  • Metallic implants in their brain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsung Medical Center

Seoul, South Korea

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 27, 2017

First Posted

December 7, 2017

Study Start

June 1, 2017

Primary Completion

December 30, 2022

Study Completion

January 26, 2023

Last Updated

March 8, 2023

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations

KR(1)